Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-α, but does not affect IL-1β, IL-6, or IL-10

被引:14
作者
de Galan, BE
Netea, MG
Smits, P
van der Meer, JWM
机构
[1] Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Nijmegen, Netherlands
[2] Univ Nijmegen, Med Ctr, Dept Pharmacol Toxicol, Nijmegen, Netherlands
关键词
diabetes mellitus; humans; hypoglycaemia; insulin; TNF alpha;
D O I
10.1016/S1043-4666(03)00113-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of the present study was to investigate the effect of hypoglycaemia on the production capacity of the proinflammatory cytokines tumour necrosis factor-alpha (TNFalpha) and interleukin-1beta (IL-1beta) in subjects with and without diabetes. Hyperinsulinaemic (360 pmol m(-2) min(-1)) stepped hypoglycaemic (5.0-3.5-2.5 mmol 1(-1)) glucose clamps were performed in eight diabetic patients and in six non-diabetic subjects, and hyperinsulinaemic normoglycaemia (5.0 mmol 1(-1)) control experiments were performed in four nondiabetic subjects. Circulating levels of cytokines and endotoxin-induced production of TNFalpha, IL-1beta IL-6, and IL-10 were assessed. The effects of insulin and adrenaline were measured in separate in vitro experiments. In non-diabetic subjects, hypoglycaernia downregulated the production capacity of TNFalpha in a concentration-dependent fashion (P = 0.007), but not of IL-1beta, IL-6, or IL-10. Compared to controls, the production capacity of TNFalpha in diabetic patients was already suppressed at normoglycaernia (P = 0.02) and only fell in response to hypoglycaemic nadir (P = 0.04). The downregulation of TNFalpha could not be explained by increased insulin or adrenaline levels. We conclude that hypoglycaemia specifically downregulates TNFalpha production capacity. Diabetic patients already have a suppressed TNFalpha production capacity at non-hypoglycaemic levels. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 29 条
[11]  
MALEFYT RD, 1991, J EXP MED, V174, P915
[12]   HIERARCHY OF GLYCEMIC THRESHOLDS FOR COUNTERREGULATORY HORMONE-SECRETION, SYMPTOMS, AND CEREBRAL-DYSFUNCTION [J].
MITRAKOU, A ;
RYAN, C ;
VENEMAN, T ;
MOKAN, M ;
JENSSEN, T ;
KISS, I ;
DURRANT, J ;
CRYER, P ;
GERICH, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (01) :E67-E74
[13]   Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro [J].
Morohoshi, M ;
Fujisawa, K ;
Uchimura, I ;
Numano, F .
DIABETES, 1996, 45 (07) :954-959
[14]   IN-VITRO PRODUCTION OF INTERLEUKIN-1, INTERLEUKIN-6, AND TUMOR-NECROSIS-FACTOR-ALPHA IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
OHNO, Y ;
AOKI, N ;
NISHIMURA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (04) :1072-1077
[15]   CYTOKINE PATTERNS IN PATIENTS AFTER MAJOR VASCULAR-SURGERY, HEMORRHAGIC-SHOCK, AND SEVERE BLUNT TRAUMA - RELATION WITH SUBSEQUENT ADULT-RESPIRATORY-DISTRESS-SYNDROME AND MULTIPLE ORGAN FAILURE [J].
ROUMEN, RMH ;
HENDRIKS, T ;
VANDERVENJONGEKRIJG, J ;
NIEUWENHUIJZEN, GAP ;
SAUERWEIN, RW ;
VANDERMEER, JWM ;
GORIS, RJA .
ANNALS OF SURGERY, 1993, 218 (06) :769-776
[16]   EFFECTS OF TRAUMA, DURATION OF HYPOTENSION, AND RESUSCITATION REGIMEN ON CELLULAR-IMMUNITY AFTER HEMORRHAGIC-SHOCK [J].
SCHMAND, JF ;
AYALA, A ;
CHAUDRY, IH .
CRITICAL CARE MEDICINE, 1994, 22 (07) :1076-1083
[17]  
SEVERN A, 1992, J IMMUNOL, V148, P3441
[18]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[19]   Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans [J].
Soop, M ;
Duxbury, H ;
Agwunobi, AO ;
Gibson, JM ;
Hopkins, SJ ;
Childs, C ;
Cooper, RG ;
Maycock, P ;
Little, RA ;
Carlson, GL .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 282 (06) :E1276-E1285
[20]   Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J].
Turner, RC ;
Holman, RR ;
Cull, CA ;
Stratton, IM ;
Matthews, DR ;
Frighi, V ;
Manley, SE ;
Neil, A ;
McElroy, K ;
Wright, D ;
Kohner, E ;
Fox, C ;
Hadden, D ;
Mehta, Z ;
Smith, A ;
Nugent, Z ;
Peto, R ;
Adlel, AI ;
Mann, JI ;
Bassett, PA ;
Oakes, SF ;
Dornan, TL ;
Aldington, S ;
Lipinski, H ;
Collum, R ;
Harrison, K ;
MacIntyre, C ;
Skinner, S ;
Mortemore, A ;
Nelson, D ;
Cockley, S ;
Levien, S ;
Bodsworth, L ;
Willox, R ;
Biggs, T ;
Dove, S ;
Beattie, E ;
Gradwell, M ;
Staples, S ;
Lam, R ;
Taylor, F ;
Leung, L ;
Carter, RD ;
Brownlee, SM ;
Fisher, KE ;
Islam, K ;
Jelfs, R ;
Williams, PA ;
Williams, FA ;
Sutton, PJ .
LANCET, 1998, 352 (9131) :837-853